Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a one-year randomised controlled trial

OBJECTIVE: To evaluate a new levonorgestrel-releasing intrauterine system (LNG-IUS) called Levosert(®) for the treatment of heavy menstrual bleeding (HMB) in comparison to the reference product Mirena(®). METHODS: A multicentre, randomised, controlled trial, in non-menopausal women diagnosed with fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mawet, Marie, Nollevaux, Fabrice, Nizet, Dominique, Wijzen, Fabienne, Gordenne, Valérie, Tasev, Niso, Segedi, Dimitrije, Marinescu, Bogdan, Enache, Andreea, Parhomenko, Vadim, Frankenne, Francis, Foidart, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133966/
https://www.ncbi.nlm.nih.gov/pubmed/24666176
http://dx.doi.org/10.3109/13625187.2014.894184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133966/
https://www.ncbi.nlm.nih.gov/pubmed/24666176
http://dx.doi.org/10.3109/13625187.2014.894184

Ejemplares similares